Skip to content

Clinical trials

Observational Diabetes Mellitus, Type 2 trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Observational Country / region: South Korea Clear all

75 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20044
20053
20064
20072
20084
20094
20101
20113
20123
20133
20145
20152
20164
20172
20183
20191
20203
20215
20224
20233
20245
20251
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed48
Unknown status10
Active, not recruiting6
Recruiting5
Enrolling by invitation3
Not yet recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S19
AstraZeneca8
Boehringer Ingelheim6
Yonsei University5
Daewoong Pharmaceutical Co. LTD.4
Bayer2
Eulji University Hospital2
Kyunghee University Medical Center2
LG Chem2
Seoul National University Bundang Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 275
Diabetes Mellitus18
Diabetes Mellitus, Type 18
Insulin Resistance3
Metabolic Syndrome3
Renal Insufficiency, Chronic3
Atherosclerosis2
Cardiovascular Diseases2
Dyslipidemias2
Non-alcoholic Fatty Liver Disease2

Trials

Showing 1 to 25 of 75. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.